93324-23-3

Upstream product

• 53712-77-9 1-bromo-3-(4-nitrophenyl)propane 
• 1074-82-4 potassium phtalimide 
• 637-59-2 1-Bromo-3-phenylpropane 

Downstream Products

• 80258-61-3 3-(4-nitrophenyl)propan-1-amine 
• 61798-01-4 4-(3-aminopropyl)aniline 
• 80266-20-2 1-[4-(Acridin-9-ylamino)-phenyl]-3-[4-(3-amino-propyl)-phenyl]-urea; hydrochloride 
• 80258-78-2 1-{4-[3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-propyl]-phenyl}-3-(4-nitro-phenyl)-urea 
• 80258-84-0 1-[4-(3-Amino-propyl)-phenyl]-3-(4-nitro-phenyl)-urea 
• 180147-82-4 tert-butyl [3-(4-aminophenyl)propyl]carbamate 
• 119744-44-4 N-(tert-Butyloxycarbonyl)-3-(4-nitrophenyl)propylamine 
• 80258-72-6 N-<3-(4-aminophenyl)propyl>phthalimide 

Relevant academic research and scientific papers

A novel series of 2-carboxytetrahydroquinolines provides new insights into the eastern region of glycine site NMDA antagonists

A series of potent 4-substituted tetrahydroquinolines has been synthesized and biologically tested in order to refine the eastern region of the pharmacophore model for glycine site NMDA antagonists concerning the assessment of lipophilicity, flexibility, and hydrogen bonding. Displacement studies on rat cortical membranes using [3H]-5,7-dichlorokynurenic acid as a radioligand indicated that binding affinities are markedly enhanced when additional hydrogen-accepting groups are introduced into the eastern region of the 2-carboxytetrahydroquinolines. Among the most potent ligands were some urea, sulfonylurea, and crown ether compounds as interesting leads for new diagnostics, especially for the evaluation of PET tracers, which allow biodistribution studies and NMDA receptor studies in the living organism.